American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2002 Jul 15;59(14):1323-4. doi: 10.1093/ajhp/59.14.1323 Q32.12024
Alosetron to return to market
阿洛司琼即将重新上市 翻译改进
作者单位 +展开
作者单位
DOI: 10.1093/ajhp/59.14.1323 PMID: 12132555
摘要 中英对照阅读
Keywords:alosetron; irritable bowel syndrome
相关内容
-
Alosetron and irritable bowel syndrome
阿洛司琼与易激综合症
Expert opinion on pharmacotherapy. 2003 Nov;4(11):2089-98.
-
Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder
抗肠易激综合征药阿洛司琼的临床应用策略
Drugs. 2003;63(18):1895-905.
-
Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds
Alosetron治疗易激综合症 GlouceSmithKline公司高级副总裁答复
BMJ (Clinical research ed.). 2003 Jan 4;326(7379):51.
-
Alosetron for irritable bowel syndrome. Risks of using alosetron are still unknown
曲普利定治疗易激综合症的风险未知
BMJ (Clinical research ed.). 2003 Jan 4;326(7379):51.
-
Alosetron for irritable bowel syndrome
曲普坦治疗易激综合症(IBS) 病人的严重腹痛及排便障碍疗效的系统评价和 meta 分析
BMJ (Clinical research ed.). 2002 Sep 14;325(7364):555-6.
-
Alosetron in irritable bowel syndrome
腹腔神经丛阻滞引起的心律失常-概念性评述及病例报告(Irritable Bowel Syndrome(irritability)的治疗-Alosetron的研究进展)
Lancet (London, England). 2000 Jul 8;356(9224):164-5.
-
Alosetron for irritable bowel syndrome
阿洛司琼治疗易激综合症
Lancet (London, England). 2000 Dec 9;356(9246):2009-10.
-
Reassessing the benefits and risks of alosetron: what is its place in the treatment of irritable bowel syndrome?
重新评估 Alosetron 的疗效和风险及其在肠易综合症治疗中的作用分析
Drug safety. 2004;27(5):283-92.